Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.76 USD | +0.76% | -1.57% | -18.89% |
04:49pm | TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
04:23pm | Jefferies Adjusts Gilead Sciences' Price Target to $80 From $95 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.89% | 81.39B | |
+25.86% | 653B | |
+27.00% | 556B | |
-6.46% | 354B | |
+20.44% | 331B | |
+3.84% | 296B | |
+13.17% | 233B | |
+5.61% | 201B | |
-9.49% | 193B | |
-6.37% | 144B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences' : Trodelvy Gets FDA's Accelerated Approval for Advanced Bladder Cancer